-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903. Health Services and Quality Improvement: Myeloid Malignancies: Poster II

Symposia: Health Services and Quality Improvement: Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Clinical trials, Clinical Practice (Health Services and Quality), Clinical Research, Health outcomes research, Diversity, Equity, and Inclusion (DEI), Health disparities research, Education, Diseases, Patient-reported outcomes, Treatment Considerations, Myeloid Malignancies
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Barbara D Lam, MD1, Satoko Ito, MD, PhD2, Justine Ryu, MD3, Kevin O'Sullivan, MD4*, Kunal C Potnis, MD5*, Roosevelt Lu4*, Aram Bidikian, MD6, Jason A Freed, MD7, Jennifer La8* and George Goshua, MD, MSc, FACP9

1Division of Hematology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA
2Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
3Section of Hematology, Yale University School of Medicine, New Haven, CT
4Beth Israel Deaconess Medical Center, Boston, MA
5Department of Internal Medicine, Yale School of Medicine, New Haven
6Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
7Division of Hematology and Hematological Malignancies, Beth Israel Deaconess, Boston, MA
8VA Boston Healthcare System, Boston, MA
9Hematology-Oncology & Yale CORE, Yale School of Medicine & Yale Cancer Center, New Haven, CT

Victoria Korsos, MD1*, Saima Ahmed, PhD2*, Sheena Heslip, NP2*, April Shamy, MD3, Rayan Kaedbey2, Sarah Matarasso Greenfeld, MD2*, Chantal Cassis, MD3 and Sarit E. Assouline, MD2

1Jewish General Hospital, Montreal, Canada
2Jewish General Hospital, McGill University, Montreal, QC, Canada
3Jewish General Hospital, McGill University, Montreal, QC, CAN

Sarah Helen Oram1*, Alice Watson2*, Claire Woodley3* and Claire Harrison4

1King's College London, London, United Kingdom
2Patient, Oxford, United Kingdom
3Department of Clinical Haematology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom
4Guy's and St Thomas' NHS Foundation Trust, London, ENG, United Kingdom

Jeffery J. Auletta, MD1, Stephanie Bo-Subait, MPH1*, Abeer Madbouly, PhD1*, Jaime M. Preussler, MS1, Janelle Olson, PhD1*, Lindsay Bankole1*, Sarah Smith1*, Martin J. Maiers, MS1*, Yung-Tsi Bolon, PhD1*, Jennifer Novakovich2*, Kelly Buck2*, Craig Malmberg2*, Kim Wadsworth2*, Stephanie Fingerson1*, Christa L Meyer, MS1*, Anna M. DeSalvo, MS, CGC1*, Katie Schoeppner, MSW, LICSW1*, Jackie Foster, MPH, RN, OCN1*, Ben Tweeten, MSW, LICSW1*, Rachel Cusatis, PhD3*, Deborah Mattila, BA1*, Caitrin Bupp, MPH1*, Juan Wu, MS1*, Larisa Broglie, MD4, Brent R. Logan, PhD4*, Bronwen E. Shaw, MD, PhD3, Heather E. Stefanski, MD, PhD1, Stephen R. Spellman1* and Steven Michael Devine, MD5

1CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN
2NMDP, Minneapolis, MN
3CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI
5Center for International Blood and Marrow Transplant Research, NMDP, Minneapolis, MN

Joseph Kim, MD, MPH1*, Ruben A. Mesa, MD2, Linda Gracie-King, MS3*, Marc David Viens, MS3*, Victor Ocana4* and Stephanie Wenick5*

1Q Synthesis LLC, Newtown, PA
2Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC
3AXIS Medical Education, Fort Lauderdale, FL
4AXIS Medical Education, Inc., Fort Lauderdale, FL
5Global Learning Collaborative, Fort Washington, PA

Manisha Dubey1*, Patricia Mae G Santos, MD2*, Katherine E Feldman, BA1*, Aman Narayan, MD3*, Sonia Persaud, MPH4*, Jennifer Santos, MD5, Melina Smith, MD6*, Emily Anderson, MD6*, Arthur Hong, MD, MPH3*, K. Robin Yabroff, PhD, MBA, FASCO7*, Fumiko Chino, MD, FASCO2*, Haley M. Simpson, MD, PhD8 and Lilia Cervantes, MD1*

1University of Colorado, Aurora, CO
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, UT Southwestern Medical Center, Dallas, TX
4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
5Division of Hospital Medicine, University of Colorado, Denver, CO
6Division of Hospital Medicine, University of Colorado, Aurora, CO
7American Cancer Society, Atlanta, GA
8Division of Hematology, University of Colorado, Aurora, CO

Melissa Barnes, DNP, RN, CENP, OCN1*, Christina Villa, BSN, RN OCN1*, Brenda Crump, MBA, MSN, RN, NE-BC1*, Donna Field, RPh, MBA1*, Seungjean Chai, MD1*, Ruben A. Mesa, MD1, Payal Desai, MD1, Sridhar Pal, MD1*, Jennifer Gray, DNP, ACNP-BC, AOCNP1* and Brittany Knick Ragon, MD2

1Atrium Health Levine Cancer Institute, Charlotte, NC
2Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC

Rachel Rodenbach, MD, MS1, Thorunn H. Thordardottir, MD2, Kah Poh Loh, MD, MBBCH BAO, MS3 and Toby Campbell, MD MSCI4*

1Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
2Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin Hospitals and Clinics, Madison, WI
3University of Rochester, Rochester, NY
4University of Wisconsin School of Medicine and Public Health, Madison

Jason Shafrin, PhD1*, Nadine Zawadzki, PhD, MPH1*, Shurui Zhang, MS2*, Paul Pinkston, PharmD3*, David Wei, PhD3* and Jennifer E Vaughn, MD4

1Center for Healthcare Economics and Policy, FTI Consulting, Los Angeles, CA
2Center for Healthcare Economics and Policy, FTI Consulting, Washington, DC
3Novartis Pharmaceuticals Corporation, East Hanover, NJ
4James Cancer Hospital and Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH

Harinder Gill, MBBS, MD, FRCP (Edin, Glasg, Lond), FRCPath, FHKCP, FHKAM (Medicine)1, Chul Won Choi2*, Hein Than, MD, FRCPath, MRCP3, Hsin-An Hou, MD, PhD, MSc4*, Chul Won Jung, MD5, Yok-Lam Kwong, MD6*, Garret M. K. Leung6*, Melissa G. M. Ooi7,8*, Ponlapat Rojnuckarin, MD9, David M. Ross10*, Lee-Yung Shih, MD11, Katsuto Takenaka12*, Winnie Z. Y. Teo, FRCPath, MRCP7,13* and Keita Kirito, MD14

1Department of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
2Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea, Republic of (South)
3Department of Haematology, Singapore General Hospital, Singapore, Singapore
4Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
5Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
6Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong
7Department of Hematology‑Oncology, National University Cancer Institute, Singapore, Singapore
8Department of Medicine, Yong Loo Lin School of Medicine, National University, Singapore, Singapore
9Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand
10Royal Adelaide Hospital and Flinders Medical Centre, Adelaide, SA, Australia
11Chang Gung Memorial Hospital‑Linkou, Chang Gung University, Taoyuan, Taiwan
12Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine, Toon, Japan
13Fast and Chronic Program, Alexandra Hospital, Singapore, Singapore
14University of Yamanashi, Chuo, Japan

Mikkael A. Sekeres, MD1, Sangeetha Venugopal, MD, MS1, Namrata S. Chandhok, MD2, Justin M. Watts, MD3, Terrence Bradley, MD4, Justin Taylor, MD1, David Sallman, MD5, Zhuoer Xie, MD, MS6, Eric Padron, MD5, Shelby Sullivan, PharmD7*, Emily Zyborowicz, MPH7*, Jeffrey Carter, PhD7*, Cherilyn Heggen, PhD7*, Lindsay Gurska, PhD7* and Rami S. Komrokji, MD8

1Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
2Sylvester Comprehensive Cancer Center, University of Miami-Miller School of Medicine, Miami, FL
3Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL
4University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
5Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
6Department of Malignant Hematology, Moffitt Cancer Center, Lutz, FL
7PRIME Education, New York, NY
8Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

Samantha E Watters, MPH1,2*, Christa L Meyer, MS3*, Jaime M. Preussler, MS3 and Mary Senneka, MBS4*

1University of Maryland School of Public Health, College Park, MD
2NMDP, Montross, VA
3CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN
4Center for International Blood and Marrow Transplant® (CIBMTR), NMDP, Minneapolis, MN

*signifies non-member of ASH